THE IMPACT OF PD-1+ INNATE-LIKE CD8+T CELLS ON THE HBSAG REDUCTION IN ACTIVE CHRONIC HEPATITIS B PATIENTS RECEIVING NUCLEOS(T) IDE ANALOGUE THERAPY

被引：0
作者：
Jeng, Rachel Wen-Juei [1 ]
Huang, Hsiang-Wei [1 ]
Lin, Chia-Wei [1 ]
Fan, Jian He [1 ]
Liu, Yen-Chun [1 ]
Ku, Wei-Ting [1 ]
Wu, Cheng-Heng [1 ]
Huang, Chien-Hao [2 ]
Lin, Yung-Chang [1 ]
Lin, Chun Yen [1 ]
机构：
[1] Chang Gung Mem Hosp, Linkou Med Ctr, Taoyuan, Taiwan
[2] Chang Gung Univ, Taoyuan, Taiwan
来源：
HEPATOLOGY | 2024年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
996
引用
收藏
页码：S755 / S756
页数：2
相关论文
共 50 条
[31]   Letter: Consensus in international guidelines when discontinuing nucleos(t)ide analogue therapy in patients with chronic hepatitis B [J].
Trinh, Steven ;
Andrew, Bridgette ;
Bloom, Stephen ;
Sawhney, Rohit .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2023, 58 (09) :954-955
[32]   Keystone to Secure Safety After Stopping Nucleos(t)ide Analogue Therapy in Chronic Hepatitis B Patients Reply [J].
Hsu, Yao-Chun ;
Tseng, Cheng-Hao ;
Nguyen, Mindie H. .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2022, 20 (08) :1891-1892
[33]   EOMESODERMIN-EXPRESSING INNATE-LIKE CD8+T CELLS IN HUMANS ARE IMPAIRED IN CHRONIC MYELOID LEUKEMIA PATIENTS AT DIAGNOSIS [J].
Herbelin, Andre ;
Jacomet, Florence ;
Cayssals, Emilie ;
Desmier, Deborah ;
Barbarin, Alice ;
Basbous, Sara ;
Levescot, Anais ;
Robin, Aurelie ;
Giraud, Christine ;
Barra, Anne ;
Guilhot, Francois ;
Roy, Lydia ;
Gombert, Jean-Marc .
JOURNAL OF IMMUNOLOGY, 2016, 196
[34]   Discrepancy Between Virological Breakthrough and Confirmed Genotypic Resistance in Chronic Hepatitis B Patients Receiving Nucleos(T)Ide Analogue Therapy in Clinical Practice [J].
Hongthanakorn, Chanunta ;
Chotiyaputta, Watcharasak ;
Oberhelman, Kelly ;
Fontana, Robert J. ;
Marrero, Jorge A. ;
Licari, Tracy L. ;
Lok, Anna S. .
GASTROENTEROLOGY, 2010, 138 (05) :S793-S793
[35]   Antiviral effect of entecavir in nucleos(t)ide analogue-naive and nucleos(t)ide analogue- experienced chronic hepatitis B patients without virological response at week 24 or 48 of therapy [J].
Chen, Chien-Hung ;
Hu, Tsung-Hui ;
Hung, Chao-Hung ;
Wang, Jing-Houng ;
Lu, Sheng-Nan ;
Lee, Chuan-Mo .
JOURNAL OF VIRAL HEPATITIS, 2014, 21 (08) :E55-E64
[36]   PREDICTION OF HBSAG LOSS USING HBSAG DECLINE AFTER LONG-TERM VIROLOGICAL RESPONSE TO NUCLEOS(T)IDE ANALOGUE THERAPY FOR CHRONIC HEPATITIS B [J].
Zoutendijk, Roeand ;
Hansen, Bettina E. ;
van Vuuren, Anneke J. ;
Boucher, Charles A. ;
Janssen, Harry L. .
HEPATOLOGY, 2010, 52 (04) :509A-509A
[37]   Increased HBsAg Decline in Sustained Responders After Discontinuation of Long-term Nucleos(t)ide Analogue Therapy in Chronic Hepatitis B [J].
Chi, Heng ;
Hansen, Bettina E. ;
Abu-Amara, Mahmoud ;
Yim, Colina ;
Arends, Pauline ;
Feld, Jordan J. ;
van der Eijk, Annemiek A. ;
de Knegt, Robert J. ;
Wong, David K. ;
Janssen, Harry L. .
HEPATOLOGY, 2014, 60 :1105A-1105A
[38]   Adding pegylated interferon to a current nucleos(t)ide therapy leads to HBsAg seroconversion in a subgroup of patients with chronic hepatitis B [J].
Kittner, Jens M. ;
Sprinzl, Martin F. ;
Grambihler, Annette ;
Weinmann, Arndt ;
Schattenberg, Joern M. ;
Galle, Peter R. ;
Schuchmann, Marcus .
JOURNAL OF CLINICAL VIROLOGY, 2012, 54 (01) :93-95
[39]   Nucleotide analogue therapy does not reverse the hyperexpression of innate-like markers on activated T cells consistent with immunopathology in chronic hepatitis B [J].
Mak, Lung Yi Loey ;
Koffas, Apostolos ;
Wellington, Sabina ;
Stretch, Sophie ;
Riddell, Anna ;
Yuen, Man-Fung ;
Kennedy, Patrick ;
Gill, Upkar .
JOURNAL OF HEPATOLOGY, 2023, 78 :S1033-S1033
[40]   IMPROVED HBsAg LOSS RATE IN CHRONIC HEPATITIS B PATIENTS TREATED WITH PROLONGED PEGINTERFERON α-2a COMBINED WITH NUCLEOS(T)IDE ANALOGUE [J].
Wang, S. Q. ;
Xu, K. J. ;
Wu, J. Z. ;
Luongo, T. T. ;
Yang, R. G. ;
Geng, X. X. ;
Huang, R. G. ;
Lin, J. M. ;
Yang, X. X. ;
Jiang, N. .
JOURNAL OF HEPATOLOGY, 2013, 58 :S317-S317
12345